AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vritmeta 35 MR Tablet

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Trimetazidine (35mg)

Overview Vritmeta 35 MR Tablet

Cardinol 35 MR tablets are prescribed for angina pectoris, a type of chest pain stemming from heart issues. This medication acts as a preventative measure against angina episodes; it won't alleviate an attack already in progress. It's suitable for standalone use or alongside other cardiac medications, as determined by your physician. Consistent daily use, as directed, is crucial, regardless of whether you're experiencing symptoms. Timing of administration (with or without food) is flexible, but consistency is key. Dosage frequency may adjust over time based on treatment efficacy. Regular intake maximizes its protective effects; discontinuation can lead to a recurrence of chest pain. Complementing this medication with lifestyle improvements—such as smoking cessation, moderate alcohol consumption, a healthy diet, regular physical activity, and stress management—further enhances cardiovascular health. Potential side effects include, but aren't limited to, nausea, vomiting, headache, dizziness, abdominal discomfort, diarrhea, skin rashes, itching, hives, and fatigue. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your physician of any existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medications you're using, as this medication may not be appropriate for everyone.

Uses of Vritmeta 35 MR Tablet

Managing chest pain associated with angina pectoris

Major Benefits of Vritmeta 35 MR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vritmeta 35 MR Tablet whole; avoid chewing, crushing, or breaking it. Consume it with food.

Common Side effects of Vritmeta 35 MR Tablet:

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Weakness
  • Rash
  • Abdominal pain
  • Indigestion
  • Itching
  • Diarrhea
  • Hives

How to use Vritmeta 35 MR Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vritmeta 35 MR Tablet with a meal.

How Vritmeta 35 MR Tablet works:

Metadol 35 MR tablets are used to treat angina. They reduce the heart's oxygen demand by altering its energy source from fatty acids to carbohydrates. This improves the heart's overall performance.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Vritmeta 35 MR Tablet and alcohol may result in significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The safety of Vritmeta 35 MR Tablet during pregnancy is undetermined. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation-related data for Vritmeta 35 MR Tablet are currently unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Vritmeta 35 MR Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vritmeta 35 MR Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Vritmeta 35 MR Tablet is contraindicated for individuals with severely compromised kidney function.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Vritmeta 35 MR Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Vritmeta 35 MR Tablet :

Should you forget a Vritmeta 35 MR Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Vritmeta 35 MR Tablet

LabelValue
Chemical Type Benzylamines
Developing Habits No.
Treatment Category Heart
Actions Fatty acid and sodium channel modulator

FAQs on Vritmeta 35 MR Tablet

Vritmeta 35 MR Tablet isn't a beta-blocker; it's an anti-anginal drug. Used alongside other medications, it treats angina pectoris (chest pain from coronary artery disease) by shielding heart cells from oxygen deprivation during angina attacks.
Avoid Vritmeta 35 MR Tablet if you're allergic to it, have severe kidney disease, or have Parkinson's disease. Parkinson's disease is a brain disorder affecting movement, causing tremors, stiffness, slow movement, and an unsteady gait.
Vritmeta 35 MR Tablet requires careful use in patients over 75. Elderly patients typically receive lower doses to minimize adverse reactions, requiring close monitoring.
Vritmeta 35 MR Tablet users may experience falls, although infrequently. This can result from gait instability or postural hypotension. Elderly patients are at increased risk and require careful monitoring.
Vritmeta 35 MR Tablets may cause dizziness or drowsiness. Avoid driving or operating machinery if affected.
Follow your doctor's instructions precisely when taking Vritmeta 35 MR Tablet. Take the tablet(s) orally with adequate liquid, such as water. This medication can be taken with or without food.
Vritmeta 35 MR Tablet may cause dizziness, headache, abdominal pain, diarrhea, indigestion, hives, rash, and itching. You may also experience nausea and weakness. Less common side effects include palpitations, orthostatic hypotension (leading to dizziness, lightheadedness, or fainting), falls, and flushing.
Vritmeta 35 MR Tablet
137
MRP 159
13% off